Based on a new study of the safety and abuse potential of psilocybin, the hallucinogenic drug in magic mushrooms, Johns Hopkins University School of Medicine researchers recommend that "psilocybin should be re-categorized from a schedule I drug—one with no known medical potential—to a schedule IV drug such as prescription sleep aids, but with tighter control."
From Johns Hopkins
"We want to initiate the conversation now as to how to classify psilocybin to facilitate its path to the clinic and minimize logistical hurdles in the future," says Matthew W. Johnson, associate professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine. "We expect these final clearance trials to take place in the next five years or so."
Following the Controlled Substances Act of 1970, any drug with the potential for abuse is categorized based on criteria that take into account whether the drug has accepted medical use, and its safety and the potential for abuse. Schedule IV drugs are those that have a low potential for abuse or dependence.
Although preliminary research studies suggest that psilocybin may be effective for smoking cessation and for disorders such as cancer-specific depression and anxiety, it must clear phase III clinical trials before the Food and Drug Administration can be petitioned to reclassify it.
Highlights from their scientific paper published in the journal Neuropharmacology:
• Psilocybin mushrooms have been used for millennia for spiritual and medical purposes.
• Animal and human studies indicate low abuse and no physical dependence potential.
• Major national surveys indicate low rates of abuse, treatment-seeking and harm.
• Psilocybin may provide therapeutic benefits supporting its development as a new drug.
• Analysis supports the scheduling of psilocybin no more restrictively than Schedule IV.
TIL: Sharks are attracted to the sound of death metal. Apparently, the “dense tones” of it mimics the “low frequencies of struggling fish.” (Damn.) In 2015, a Discovery Channel crew — hoping to attract a large great white named “Joan of Shark” — dropped a speaker underwater and played some. Independent: Desperate to feature the […]
The mystery of the glorious fireball emitted by microwaved grapes (featured in my novel Little Brother) has been resolved, thanks to a paper in the Proceedings of the National Academy of Sciences in which Trent University researchers Hamza Khattak and Aaron Slepkov explain how they destroyed a dozen microwaves before figuring out that the grapes […]
The rise in a belief that the Earth is flat is bizarre and somewhat frightening, a repudiation of one of the most basic elements of scientific consensus. Texas Tech University psych researcher Asheley R. Landrum attended a 2017 flat earth convention and interviewed 30 attendees to trace the origins of their belief in a flat […]
Use a single password for every website, and you’re compromising your security. Use a different one each time, and you’re bound to lose track of them. The solution? RoboForm Everywhere, a catch-all tool that will not only manage the passwords on every site you visit but generate better ones. As a simple password database, it’s […]
Just a reminder: Print isn’t dead. And now that printers are becoming as portable as cell phones, it might be around for quite some time. Enter the MEMOBIRD Mobile Thermal Printer, a mini-printer that is versatile, portable – and most importantly, never needs a refill on ink or toner. Measuring just a few inches around, […]
What do Facebook, Twitter, YouTube and Google all have in common? Somewhere in their framework, they all use MySQL, that most versatile (and free!) of database management systems. And they’re not alone. If your company or the one you’d like to work for wrangles data (and who doesn’t?), they’re going to need someone with a […]